KRAS and lung cancer: As such, whole-exome and whole-genome sequencing approaches have been used to characterize the mutational landscapes of Kras-mutant mouse skin squamous cell carcinoma [71] and Egfr-, Myc- and Kras-driven lung cancers [72,73].